HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Guz, G. Articles by Sindel, S. Search for Related Content PubMed PubMed Citation Articles by Guz, G. Articles by Sindel, S.

PROCALCITONIN AND CONVENTIONAL MARKERS OF INFLAMMATION IN PERITONEAL DIALYSIS PATIENTS AND PERITONITIS

Department of Nephrology¹ and Department of Infectious Disease,² Gazi University Faculty of Medicine Cankaya, Ankara, Turkey

Correspondence to: G. Guz, Department of Nephrology, Gazi University Faculty of Medicine, 06510 Besevler, Ankara, Turkey.
Turkey.galipguz{at}gazi.edu.tr; galip_guz{at}hotmail.com

• Objectives: To determine the significance of a newly described marker of inflammation procalcitonin (PCT), and to investigate its relationship to conventional markers of inflammation, such as C-reactive protein (CRP), fibrinogen, and erythrocyte sedimentation rate (ESR), in patients on peritoneal dialysis (PD) and with peritonitis.
  
• Design: A prospective, observational clinical study.
  
• Setting: The Nephrology Division of a University-affiliated teaching hospital.
  
• Patients and Methods: 51 consecutive patients on PD were included in the study. Of this number, 16 developed peritonitis during the observational period. Baseline PCT, CRP, and fibrinogen concentrations and ESR of 51 PD patients were determined at a time point (T_B) prior to any evidence of infection. These results were compared with laboratory values from 74 hemodialysis patients and 34 nonuremic control subjects. All PD patients then were followed prospectively for evidence of peritonitis. In addition to routine blood tests, including hemoglobin and leukocyte count, and routine biochemical tests, blood samples were taken to measure PCT, CRP, and fibrinogen concentrations and ESR at the time (T₀) when patients first were diagnosed with PD peritonitis and also on the 4th (T₄) and the 14th (T₁₄) days after treatment for peritonitis was initiated. PCT was assayed by immunoluminometry.
  
• Results: No significant difference was observed between baseline median serum PCT concentrations in PD and hemodialysis patients; however, in both groups, baseline median PCT concentrations were significantly higher than those of nonuremic controls (p < 0.05). The 16 patients on PD who developed peritonitis had 21 PD peritonitis episodes during the study period. The increased PCT concentration observed at T₀ in PD peritonitis episodes decreased with therapy, and this change was statistically significant (p < 0.05). In a receiver operating characteristic curve analysis for peritonitis, the area under the curve (AUC) for PCT was 0.80, which was significantly lower than the AUC for CRP and greater than the AUCs for fibrinogen and ESR. The sensitivity of PCT for peritonitis was lower than the sensitivity of conventional markers of inflammation; however, the specificity of PCT was higher.
  
• Conclusions: Median serum PCT concentration in PD patients was significantly higher than in nonuremic controls but not hemodialysis patients. Serum PCT concentrations may serve as a useful adjunct to traditional markers of inflammation in detecting and monitoring inflammation and peritonitis in PD patients.
  

KEY WORDS: Procalcitonin; inflammation markers; peritonitis.

Received 3 August 2004; accepted 31 July 2005.

Copyright © 2006 by Multimed Inc.